Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3974557019 | Vaccine product containing only live attenuated Human poliovirus serotypes 1, 2, and 3 antigens in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT core module |
| 3974558012 | Live attenuated poliovirus serotypes 1, 2, and 3 vaccine in parenteral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3974559016 | Live attenuated Human poliovirus serotypes 1, 2, and 3 antigens only vaccine product in parenteral dose form | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Vaccine product containing only live attenuated Human poliovirus serotypes 1, 2, and 3 antigens in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Vaccine product containing only live attenuated Human poliovirus serotypes 1, 2, and 3 antigens in parenteral dose form (medicinal product form) | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Vaccine product containing only live attenuated Human poliovirus serotypes 1, 2, and 3 antigens in parenteral dose form (medicinal product form) | Plays role | Active immunity stimulant role | false | Inferred relationship | Existential restriction modifier | ||
| Vaccine product containing only live attenuated Human poliovirus serotypes 1, 2, and 3 antigens in parenteral dose form (medicinal product form) | Count of active ingredient | 3 | false | Inferred relationship | Existential restriction modifier | ||
| Vaccine product containing only live attenuated Human poliovirus serotypes 1, 2, and 3 antigens in parenteral dose form (medicinal product form) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Vaccine product containing only live attenuated Human poliovirus serotypes 1, 2, and 3 antigens in parenteral dose form (medicinal product form) | Has active ingredient | Antigen of live attenuated Human poliovirus serotype 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Vaccine product containing only live attenuated Human poliovirus serotypes 1, 2, and 3 antigens in parenteral dose form (medicinal product form) | Has active ingredient | Antigen of live attenuated Human poliovirus serotype 3 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Vaccine product containing only live attenuated Human poliovirus serotypes 1, 2, and 3 antigens in parenteral dose form (medicinal product form) | Has active ingredient | Antigen of live attenuated Human poliovirus serotype 2 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Vaccine product containing only live attenuated Human poliovirus serotypes 1, 2, and 3 antigens in parenteral dose form (medicinal product form) | Is a | Vaccine product containing only Human poliovirus antigen (medicinal product) | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR